Georgia Healthcare Group PLC (“GHG” or the “Group” – LSE: GHG LN), announces the Group’s fourth quarter and full year 2019 consolidated financial results. Unless otherwise mentioned, comparatives are for the fourth quarter of 2018. The results are based on International Financial Reporting Standards (“IFRS”) as adopted in the European Union (“EU”), are unaudited and extracted from management accounts.
GHG announces today the Group’s 4Q19 and FY19 consolidated results, reporting 13.3% y-o-y growth in full year revenues to GEL 963.1 million (US$335.8 million/GBP 256.2 million) and a 100 basis point improvement in adjusted ROIC2. The Group posted full year profit of GEL 69.1 million (US$24.1 million/GBP 18.4 million) and earnings per share (“EPS”) of GEL 0.36 (US$0.12 per share/GBP 0.09 per share), both excluding IFRS 16 lease accounting impact.